← Eichor
Condition: Active Systemic Juvenile Idiopathic Arthritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Active Systemic Juvenile Idiopathic Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Even
Phase 3 · 47 location(s) · AbbVie · NCT05609630To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic A
NA · 10 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT05925452
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.